buserelin has been researched along with Lung Neoplasms in 22 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (50.00) | 18.7374 |
1990's | 10 (45.45) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (4.55) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Duensing, S; Grüllich, C; Hadaschik, BA; Höfner, T; Hohenfellner, M; Jäger, D; Pahernik, S; Vallet, S | 1 |
Kido, M; Kodate, M; Nagata, N; Nikaido, Y; Shirakusa, T; Tao, Y; Tsuda, T; Yoshii, C | 1 |
de Voogt, H; Denis, L; Sylvester, RJ | 1 |
Kiesel, L; van Groeninghen, JC; Winkler, D; Zwirner, M | 1 |
Broux, R; Corhay, JL; Limet, R; Radermecker, M | 1 |
Balbi, B; Lantero, S; Oddera, S; Ravazzoni, C; Rossi, GA | 1 |
Baldelli, S; Cellerino, R; Menichetti, ET; Miseria, S; Murer, B; Torresi, U; Tummarello, D | 1 |
Borlée, G; Broux, R; Bury, T; Corhay, JL; Gaspard, U; Gustin, M; Limet, R; Noël, F; Radermecker, MA; Saint-Remy, P | 1 |
Armengol, J; Bella, F; Calaf, J; Espaulella, J; Lain, JM | 1 |
Blamey, RW; Griffiths, K; Pearson, D; Turkes, A; Williams, MR | 2 |
Heyman, J; Leiter, E | 1 |
Castoldi, R; Di Carlo, V; Di Palo, S; Mari, G; Staudacher, C; Taccagni, G | 1 |
Dal Bo, V; Della Valentina, M; Francini, M; Lo Re, G; Magri, MD; Merlo, A; Monfardini, S; Talamini, R; Veronesi, A | 1 |
Huhtaniemi, I; Kauppila, A; Martikainen, H; Penttinen, J | 1 |
Argüelles, AE; Lascano, A; Poggi, U; Volmer, MC | 1 |
Nicholson, RI; Plowman, PN; Walker, KJ | 1 |
Blamey, RW; Robertson, JF | 1 |
Abdulwahid, NA; Craft, I; Hague, WM; Jacobs, HS | 1 |
Falkson, G; Vorobiof, DA | 1 |
Ackman, CF; Koutsilieris, M | 1 |
Farid, NR; Jean, C; Maheux, R; Parent, JG; Samson, Y | 1 |
1 trial(s) available for buserelin and Lung Neoplasms
Article | Year |
---|---|
The importance of prognostic factors in the interpretation of two EORTC metastatic prostate cancer trials. European Organization for Research and Treatment of Cancer (EORTC) Genito-Urinary Tract Cancer Cooperative Group.
Topics: Aged; Analysis of Variance; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Buserelin; Combined Modality Therapy; Cyproterone Acetate; Disease-Free Survival; Flutamide; Goserelin; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Orchiectomy; Prognosis; Proportional Hazards Models; Prostatic Neoplasms; Risk Assessment; Survival Rate | 1998 |
21 other study(ies) available for buserelin and Lung Neoplasms
Article | Year |
---|---|
Docetaxel followed by abiraterone in metastatic castration-resistant prostate cancer: efficacy and predictive parameters in a large single center cohort.
Topics: Aged; Androgen Antagonists; Androstenes; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Buserelin; Cohort Studies; Disease-Free Survival; Docetaxel; Flutamide; Humans; Leuprolide; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Nitriles; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Taxoids; Tosyl Compounds; Treatment Outcome; Triptorelin Pamoate | 2015 |
[Two cases of pulmonary lymphangioleiomyomatosis].
Topics: Adult; Buserelin; Female; Humans; Lung; Lung Neoplasms; Lymphangioleiomyomatosis; Progesterone; Recurrence | 1993 |
Effects of luteinising-hormone-releasing hormone on nervous-system tumours.
Topics: Brain; Brain Neoplasms; Buserelin; Carcinoma, Squamous Cell; Chordoma; Glioblastoma; Glioma; Gonadotropin-Releasing Hormone; Humans; Iodine Radioisotopes; Lung Neoplasms; Meningioma; Progesterone; Radiopharmaceuticals; Receptors, LHRH; Receptors, Progesterone; Spinal Cord Neoplasms | 1998 |
Failure of buserelin-induced medical castration to control pulmonary lymphangiomyomatosis in two patients.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Drug Evaluation; Female; Humans; Lung Neoplasms; Lymphangiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovary; Pneumothorax; Recurrence; Tamoxifen | 1992 |
Response to treatment with an analog of the luteinizing-hormone-releasing hormone in a patient with pulmonary lymphangioleiomyomatosis.
Topics: Adult; Buserelin; Estradiol; Female; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Goserelin; Humans; Lung; Lung Neoplasms; Lymphangiomyoma; Progesterone; Radiography; Testosterone | 1991 |
Lymphangitic carcinomas of the lung as presentation of prostatic cancer. A case report.
Topics: Buserelin; Carcinoma; Flutamide; Goserelin; Humans; Lung Neoplasms; Lymphangitis; Male; Middle Aged; Prostatic Neoplasms | 1991 |
[Apropos of 2 cases of lymphangiomyomatosis treated with LH-RH agonists].
Topics: Adult; Antineoplastic Agents; Buserelin; Female; Humans; Lung Neoplasms; Lymphangiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Tomography, X-Ray Computed | 1991 |
Pulmonary endometriosis: conservative treatment with GnRH agonists.
Topics: Administration, Intranasal; Adult; Antineoplastic Agents; Buserelin; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hemoptysis; Hormones; Humans; Leuprolide; Lung Neoplasms; Pneumothorax; Triptorelin Pamoate | 1991 |
An objective biochemical assessment of therapeutic response in metastatic breast cancer: a study with external review of clinical data.
Topics: Biomarkers, Tumor; Blood Sedimentation; Bone Neoplasms; Breast Neoplasms; Buserelin; C-Reactive Protein; Carcinoembryonic Antigen; Female; Ferritins; Goserelin; Humans; Lung Neoplasms; Megestrol; Megestrol Acetate; Orosomucoid; Ovariectomy; Tamoxifen | 1990 |
Serum ferritin as a marker of therapeutic response in stage III and IV breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Buserelin; Female; Ferritins; Follow-Up Studies; Goserelin; Humans; Lung Neoplasms; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Staging; Ovariectomy; Remission Induction; Retrospective Studies; Tamoxifen | 1990 |
Dramatic response of pulmonary metastasis from prostatic cancer to LH-RH agonist treatment.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Buserelin; Gonadotropin-Releasing Hormone; Humans; Lung Neoplasms; Male; Prostatic Neoplasms; Rectal Diseases; Ulcer | 1989 |
Endometriosis of the lung.
Topics: Adult; Buserelin; Danazol; Endometriosis; Female; Humans; Lung; Lung Neoplasms; Radiography, Thoracic | 1989 |
Buserelin treatment of advanced prostatic cancer: a phase II study.
Topics: Aged; Bone Neoplasms; Buserelin; Drug Evaluation; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prostatic Neoplasms; Remission Induction | 1989 |
Gonadotropin-releasing hormone agonist analog therapy effective in ovarian granulosa cell malignancy.
Topics: Bone Neoplasms; Buserelin; Female; Goserelin; Granulosa Cell Tumor; Humans; Lung Neoplasms; Middle Aged; Ovarian Neoplasms; Pituitary Hormone-Releasing Hormones | 1989 |
Lung metastases of prostate carcinoma cleared by intranasal GRH analogue.
Topics: Adenocarcinoma; Administration, Intranasal; Aged; Buserelin; Humans; Lung Neoplasms; Male; Prostatic Neoplasms | 1985 |
Remission of postmenopausal breast cancer during treatment with the luteinising hormone releasing hormone agonist ICI 118630.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Buserelin; Female; Follicle Stimulating Hormone; Goserelin; Humans; Lung Neoplasms; Luteinizing Hormone; Menopause; Middle Aged; Remission Induction | 1986 |
Response in post-menopausal patients on ICI 118630.
Topics: Bone Neoplasms; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Lung Neoplasms; Middle Aged | 1987 |
Use of LHRH analogue to obtain reversible castration in a patient with benign metastasizing leiomyoma.
Topics: Adult; Buserelin; Female; Humans; Leiomyoma; Lung Neoplasms; Ovariectomy; Ovary; Uterine Neoplasms | 1986 |
Nasally administered buserelin inducing complete remission of lung metastases in male breast cancer.
Topics: Administration, Intranasal; Breast Neoplasms; Buserelin; Humans; Lung Neoplasms; Male; Middle Aged | 1987 |
Complete response of lung metastases caused by prostatic cancer after chronic administration of a gonadotropin-releasing hormone analog, buserelin (HOE 766).
Topics: Adenocarcinoma; Aged; Buserelin; Humans; Lung; Lung Neoplasms; Male; Prostatic Neoplasms; Radiography | 1987 |
Utilization of luteinizing hormone-releasing hormone agonist in pulmonary leiomyomatosis.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Buserelin; Dyspnea; Estradiol; Female; Humans; Leiomyoma; Lung Neoplasms; Ovariectomy; Pain; Uterine Neoplasms | 1987 |